Takara Bio Inc. (TYO:4974)

Takara Bio Statistics

Total Valuation

Takara Bio has a market cap or net worth of JPY 111.87 billion. The enterprise value is 90.21 billion.

Market Cap	111.87B
Enterprise Value	90.21B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Takara Bio has 120.42 million shares outstanding.

Current Share Class	120.42M
Shares Outstanding	120.42M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	9.12%
Float	44.89M

Valuation Ratios

The trailing PE ratio is 193.87 and the forward PE ratio is 42.59.

PE Ratio	193.87
Forward PE	42.59
PS Ratio	2.44
PB Ratio	1.02
P/TBV Ratio	1.33
P/FCF Ratio	n/a
P/OCF Ratio	34.72
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.28, with an EV/FCF ratio of -14.45.

EV / Earnings	156.34
EV / Sales	1.97
EV / EBITDA	13.28
EV / EBIT	43.12
EV / FCF	-14.45

Financial Position

The company has a current ratio of 4.93

Current Ratio	4.93
Quick Ratio	3.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	16.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	1.74%
Revenue Per Employee	25.75M
Profits Per Employee	324,340
Employee Count	1,779
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Takara Bio has paid 1.10 billion in taxes.

Income Tax	1.10B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.20% in the last 52 weeks. The beta is 0.33, so Takara Bio's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-5.20%
50-Day Moving Average	882.28
200-Day Moving Average	888.69
Relative Strength Index (RSI)	57.20
Average Volume (20 Days)	521,285

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Takara Bio had revenue of JPY 45.81 billion and earned 577.00 million in profits. Earnings per share was 4.79.

Revenue	45.81B
Gross Profit	26.72B
Operating Income	2.09B
Pretax Income	1.72B
Net Income	577.00M
EBITDA	6.80B
EBIT	2.09B
Earnings Per Share (EPS)	4.79

Balance Sheet

The company has 22.01 billion in cash and n/a in debt, giving a net cash position of 22.01 billion or 182.75 per share.

Cash & Cash Equivalents	22.01B
Total Debt	n/a
Net Cash	22.01B
Net Cash Per Share	182.75
Equity (Book Value)	109.44B
Book Value Per Share	905.92
Working Capital	37.42B

Cash Flow

In the last 12 months, operating cash flow was 3.22 billion and capital expenditures -9.46 billion, giving a free cash flow of -6.24 billion.

Operating Cash Flow	3.22B
Capital Expenditures	-9.46B
Free Cash Flow	-6.24B
FCF Per Share	-51.84

Margins

Gross Margin	n/a
Operating Margin	4.57%
Pretax Margin	3.76%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 17.00, which amounts to a dividend yield of 1.85%.

Dividend Per Share	17.00
Dividend Yield	1.85%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.87%
Earnings Yield	0.52%
FCF Yield	-5.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 29, 2011. It was a forward split with a ratio of 400.

Last Split Date	Mar 29, 2011
Split Type	Forward
Split Ratio	400

Scores

Altman Z-Score	n/a
Piotroski F-Score	4